Most Clicked StoriesMore >


Radioimmunotherapy agent from Eckert & Ziegler targets pancreatic cancer

SNMMI SmartBrief | Oct 27, 2014

Eckert & Ziegler has partnered with a U.S. firm to develop a radioimmunotherapy agent to fight pancreatic cancer. At its plant in Germany, the company will manufacture the agent by combining antibodies with the radioisotope yttrium-90. AuntMinnie.com (free registration) (10/24)


Study backs further exploration of lymphatic mapping in ovarian cancer

SNMMI SmartBrief | Oct 30, 2014

Team generates stem cells that produce cancer-killing toxins

SNMMI SmartBrief | Oct 27, 2014

PET looks at effects of psychodynamic psychotherapy

SNMMI SmartBrief | Oct 28, 2014

Scientists develop blood test for Alzheimer's disease

SNMMI SmartBrief | Oct 29, 2014

Call for abstracts: The 3rd Theranostics World Congress Ga-68 and PRRT

SNMMI SmartBrief | Oct 28, 2014

Study explores link between Down syndrome and Alzheimer's

SNMMI SmartBrief | Oct 27, 2014

ABT receives $15M funding boost to expand globally

SNMMI SmartBrief | Oct 30, 2014

Google X seeks to develop diagnostic nanoparticles and device

SNMMI SmartBrief | Oct 29, 2014

Study IDs factors linked to dementia risks in Parkinson's

SNMMI SmartBrief | Oct 24, 2014


Find SNMMI SmartBrief Issues by Date:



SNMMI News More >


Ebola: What you should know about management and response

SNMMI SmartBrief | Oct 31, 2014

New! SNMMI's 2014 Virtual Meeting offers CE credit

SNMMI SmartBrief | Oct 31, 2014

Renew your SNMMI membership

SNMMI SmartBrief | Oct 30, 2014

State-of-the-Art Molecular Imaging in Cancer Biology and Therapy conference abstract deadline: Friday

SNMMI SmartBrief | Oct 30, 2014

Complimentary webinar: Professional Liability Risks in an Imaging Practice: How to Avoid Becoming a Statistic

SNMMI SmartBrief | Oct 29, 2014




Sign up for SNMMI SmartBrief



Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more